Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Atorvastatin improves erectile function in men with hypercholesterolemia-related ED

July 19, 2004

European marketing authorization for Vesicare for overactive bladder

July 12, 2004

Aminoalcohol derivatives for the treatment of urinary incontinence

July 9, 2004

NexMed and Schering AG sign Alprox-TD agreement

July 8, 2004

BioXell acquires from Roche rights to new indications for BXL-628

July 6, 2004

Vasopressin V2 receptor antagonist effective aquaretic in vivo

July 2, 2004

NX-1207 shows potential as a front-line treatment for BPH in phase I/II trials

July 2, 2004

The efficacy of vardenafil in ED is not affected by glycemic control or diabetes

July 1, 2004

Theravance presents new muscarinic M2 antagonists with utility in overactive bladder

June 28, 2004

New IP receptor antagonists and their use in urological disorders claimed by Bayer

June 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...